DK112191B - Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer. - Google Patents
Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer.Info
- Publication number
- DK112191B DK112191B DK446164AA DK446164A DK112191B DK 112191 B DK112191 B DK 112191B DK 446164A A DK446164A A DK 446164AA DK 446164 A DK446164 A DK 446164A DK 112191 B DK112191 B DK 112191B
- Authority
- DK
- Denmark
- Prior art keywords
- dragees
- granules
- tablets
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 239000008298 dragée Substances 0.000 title 1
- 239000007903 gelatin capsule Substances 0.000 title 1
- 239000008187 granular material Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003826 tablet Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1115563 | 1963-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK112191B true DK112191B (da) | 1968-11-18 |
Family
ID=4370622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK446164AA DK112191B (da) | 1963-09-10 | 1964-09-10 | Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer. |
Country Status (10)
Country | Link |
---|---|
US (1) | US3431338A (es) |
BE (1) | BE652807A (es) |
BR (1) | BR6462426D0 (es) |
DE (1) | DE1204363B (es) |
DK (1) | DK112191B (es) |
ES (1) | ES303909A1 (es) |
FR (1) | FR4213M (es) |
GB (1) | GB1017674A (es) |
IL (1) | IL21981A (es) |
NL (1) | NL6410434A (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1115596B (it) * | 1978-03-13 | 1986-02-03 | Bayer Italia Spa | Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
WO1981002671A1 (en) * | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
ZA825384B (en) * | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
FR2532177A1 (fr) * | 1982-08-30 | 1984-03-02 | Being Well Products Inc | Complement nutritionnel a zones de liberation determinees et son procede de fabrication |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
WO1985003436A1 (en) * | 1984-02-10 | 1985-08-15 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
US4668517A (en) * | 1985-04-04 | 1987-05-26 | Norwich Eaton Pharmaceuticals, Inc. | Furazolidone dosage form |
US4775536A (en) * | 1986-02-24 | 1988-10-04 | Bristol-Myers Company | Enteric coated tablet and process for making |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4857337A (en) * | 1988-05-24 | 1989-08-15 | American Home Products Corp. (Del) | Enteric coated aspirin tablets |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
US4965089A (en) * | 1989-04-10 | 1990-10-23 | Sauter Manufacturing Corp. | Method and apparatus for the gelatin coating of caplets |
US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
US5843479A (en) * | 1993-02-26 | 1998-12-01 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
ATE357221T1 (de) | 1994-04-22 | 2007-04-15 | Astellas Pharma Inc | Kolon-spezifisches arzneistofffreisetzungssystem |
US5637319A (en) * | 1995-03-01 | 1997-06-10 | Takada; Kanji | Controlled-release preparations |
US5686106A (en) * | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
US8563522B2 (en) * | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
US20020035071A1 (en) * | 1997-07-08 | 2002-03-21 | Josef Pitha | Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites |
US20060116330A1 (en) * | 1997-07-08 | 2006-06-01 | The Iams Company | Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
US6296876B1 (en) | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
US8168170B2 (en) * | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US20050042277A1 (en) * | 2003-07-17 | 2005-02-24 | Irukulla Srinivas | Pharmaceutical compositions having a swellable coating |
US20050158294A1 (en) * | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US7785635B1 (en) * | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US20050152884A1 (en) * | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US7670624B2 (en) * | 2004-01-29 | 2010-03-02 | Astella Pharma Inc. | Gastrointestinal-specific multiple drug release system |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
EP2270131A1 (en) * | 2005-05-31 | 2011-01-05 | The Iams Company | Feline probiotic lactobacilli |
WO2006130188A1 (en) * | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic bifidobacteria |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
RU2436581C2 (ru) | 2007-02-01 | 2011-12-20 | Дзе Иамс Компани | Способ уменьшения воспаления и снижения стресса у млекопитающего |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
US10799460B2 (en) | 2011-09-07 | 2020-10-13 | Roland SAUR-BROSCH | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2957804A (en) * | 1958-06-06 | 1960-10-25 | Harlan R Shuyler | Pesticide |
-
1964
- 1964-08-14 DE DEH53530A patent/DE1204363B/de active Pending
- 1964-08-26 IL IL21981A patent/IL21981A/en unknown
- 1964-09-04 GB GB36293/64A patent/GB1017674A/en not_active Expired
- 1964-09-07 FR FR987258A patent/FR4213M/fr not_active Expired
- 1964-09-08 BR BR162426/64A patent/BR6462426D0/pt unknown
- 1964-09-08 NL NL6410434A patent/NL6410434A/xx unknown
- 1964-09-08 BE BE652807D patent/BE652807A/xx unknown
- 1964-09-09 ES ES0303909A patent/ES303909A1/es not_active Expired
- 1964-09-10 DK DK446164AA patent/DK112191B/da unknown
-
1968
- 1968-02-29 US US709179A patent/US3431338A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BR6462426D0 (pt) | 1973-08-07 |
FR4213M (es) | 1966-06-13 |
BE652807A (es) | 1965-03-08 |
US3431338A (en) | 1969-03-04 |
GB1017674A (en) | 1966-01-19 |
IL21981A (en) | 1968-02-26 |
ES303909A1 (es) | 1965-07-16 |
NL6410434A (es) | 1965-03-11 |
DE1204363B (de) | 1965-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK112191B (da) | Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer. | |
DK128053B (da) | Fremgangsmåde til fremstilling af farmaceutiske kapsler af hydroxyalkylalkylcelluloseethere. | |
DK125957B (da) | Fremgangsmåde til fremstilling af mavesaftresistente, tyndtarmopløselige gelatinekapsler. | |
DK125207B (da) | Fremgangsmåde til fremstilling af dispersionsforstærkede zirconiumprodukter. | |
DK104194C (da) | Fremgangsmåde til fremstilling af lægemidler i form af tabletter eller lignende smålegemer. | |
DK136246B (da) | Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner. | |
DK127923B (da) | Fremgangsmåde til fremstilling af maltitol. | |
DK116020B (da) | Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan. | |
DK122789B (da) | Fremgangsmåde til fremstilling af faste doseringsenheder, som hurtigt falder hen. | |
DK118301B (da) | Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf. | |
DK140697B (da) | Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin. | |
OA03402A (fr) | Procédé de préparation de nouvelles compositions anthelminthiques. | |
DK134489B (da) | Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider. | |
DK128496B (da) | Fremgangsmåde til fremstilling af 5-fluoruracilderivater. | |
DK118420B (da) | Fremgangsmåde til fremstilling af pressede tabletter. | |
DK122708B (da) | Fremgangsmåde til fremstilling af farmaceutiske tabletter med langvarig virkning. | |
DK128674B (da) | Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning. | |
DK121922B (da) | Fremgangsmåde til fremstilling af formede tabletter. | |
DK119255B (da) | Fremgangsmåde til fremstilling af d- og 1-carnitinchlorid. | |
IL36285A0 (en) | Erythromycylamine compounds,processes for preparation thereof and pharmaceutical compositions containing them | |
DK126504B (da) | Fremgangsmåde til fremstilling af 1,2-disubstituerede 4-pyrazolidinoler. | |
DK125468B (da) | Analogifremgangsmåde til fremstilling af piperazinium-mono-(acetylsalicylat). | |
FI52096C (fi) | Menetelmä analgeettisesti aktiivisten 2,3-dihydrotiatsolo(3.2.a)pyrimi diini-5-onien valmistamiseksi | |
DK124880B (da) | Fremgangsmåde til fremstilling af Δ<1,3,5(10)>-steroider af østranrækken. | |
DK124331B (da) | Analogifremgangsmåde til fremstilling af 14β-hydroksy-15α-acyloksy-4,20(22)-kardadienolider. |